Abstract
Patients on digitalis medication at the time of diagnosis of breast cancer seem to develop tumors that have a lower growth potential than do patients not on such medication. These tumors are photometrically characterized by small nuclei with lower DNA-RNA content and less variation in morphometric characteristics.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Breast Neoplasms / pathology*
-
Cardiac Glycosides / therapeutic use*
-
Cell Nucleus / pathology
-
Computers
-
Digitoxin / therapeutic use*
-
Digoxin / therapeutic use*
-
Female
-
Humans
-
Lymphatic Metastasis
-
Neoplasm Metastasis
-
Statistics as Topic
Substances
-
Cardiac Glycosides
-
Digoxin
-
Digitoxin